Adaptive Biotechnologies Corporation
ADPT | NASDAQ
$27.86
-$0.75 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$28.06
+$0.20 (+0.72%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $4.58B
Enterprise Value $4.53B
Beta 2.10
Average Volume 2.59M
Shares Outstanding (Diluted) 157.7M
Shares Change YoY 3.69%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US00650F1093
Price Performance
Price Change 1M 7.9%
Price Change 3M -59.6%
Price Change 6M -50.8%
Price Change YTD -56.2%
Price Change 1Y -50.0%
Price Change 3Y 37.4%
Price Change 5Y -80.9%
1M CAGR (ann.) 21.2%
1Y CAGR (ann.) 123.2%
5Y CAGR (ann.) -5.6%
All-Time CAGR -4.6%
Valuation
PE Ratio -67.95
Forward PE N/A
PEG Ratio -1.39
Forward PEG 1.04
PS Ratio 14.47
Forward PS 12.40
PB Ratio 31.20
P/FCF Ratio -185.52
P/Adj. FCF Ratio -74.56
P/OCF Ratio -214.31
EV/Sales 14.69
EV/EBIT -140.99
EV/EBITDA -283.49
EV/FCF -188.28
Earnings Yield -1.5%
FCF Yield -0.5%
Adj. FCF Yield -1.3%
Financial Health
Net Cash $556K
Total Debt $410.5M
Cash & Short-Term Investments $344.26M
Total Assets $640.68M
Current Ratio 4.79
Quick Ratio 4.68
Debt / Equity Ratio 2.87
Debt / EBITDA -25.72
Debt / FCF -17.08
OCF / Debt -0.05
Interest Coverage -3.26
Altman Z-Score 3.44
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 75.4%
Operating Profit Margin -12.2%
EBITDA Margin -5.2%
Net Profit Margin -20.7%
FCF Margin -7.8%
Adj. FCF Margin -19.4%
SBC / Revenue 11.6%
SBC Impact (per share) -148.8%
Returns
Return on Assets -10.0%
Return on Equity -32.6%
Return on Invested Capital -6.7%
Return on Capital Employed -6.8%
Return on Tangible Assets -12.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 17.6%
Revenue CAGR 5Y 18.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 58.9%
EPS CAGR 5Y 25.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y 69.4%
FCF CAGR 5Y 39.8%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 52.0%
Revenue Growth Next 3Y 20.9%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.10
EPS Growth Est (next Q) -266.7%
Revenue Est (next Q) $71.65M
Revenue Growth Est (next Q) -23.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $24.38
Price Target Upside -12.5%
Cash Flow
Operating Cash Flow $-21.01M
Free Cash Flow $-24.03M
Adj. Free Cash Flow $-59.8M
FCF Per Share -$0.15
OCF Per Share -$0.13
OCF/S Ratio -6.8%
Income Statement
Revenue $308.08M
Gross Profit $232.4M
Operating Income $-37.46M
EBITDA $-15.96M
Net Income $-63.85M
EPS (Diluted) -$0.41
Revenue / Employee $493.72K
Profit / Employee $-102.33K
Employees 624
Add to Watchlist
Select watchlists to add or remove ADPT